DV
Dividend Vision

GCTK — GlucoTrack Inc

GlucoTrack Inc (GCTK)

Total return is -100.0% over the past 13.3 years, 614.0 points behind SPY at 514.0%. Its deepest 1-year drawdown was 97.3%.

GlucoTrack is a medical device company developing an implantable continuous blood glucose monitor for Type 1 and insulin-dependent Type 2 diabetes patients in the United States. The company does not currently distribute dividends. GlucoTrack appeals to investors seeking exposure to the medical device sector rather than those focused on generating current income.

GCTK key facts

Asset type
Stock
Asset class
Equity
Inception date
04/25/2013
Last close
$0.37
Market cap
$3,227,165
Average volume
592400.0
Beta
0.764
Payout ratio
0.0
P/E ratio
0.0785
Forward P/E
0.0
EPS
$6.27